Citadel Advisors
ARVN icon

Citadel Advisors’s Arvinas ARVN Stock Holding History

Citadel Advisors’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147K Buy
17,700
+6,300
+55% +$58.8K ﹤0.01% 12368
2026
Q1 		$121K Sell
11,400
-21,600
-65% -$268K ﹤0.01% 11859
2025
Q4 		$391K Sell
33,000
-143,100
-81% -$1.56M ﹤0.01% 9585
2025
Q3 		$1.5M Sell
176,100
-80,000
-31% -$607K ﹤0.01% 6676
2025
Q2 		$1.88M Buy
256,100
+31,300
+14% +$231K ﹤0.01% 5808
2025
Q1 		$1.58M Buy
224,800
+168,500
+299% +$2.64M ﹤0.01% 5992
2024
Q4 		$1.08M Buy
56,300
+38,800
+222% +$943K ﹤0.01% 6854
2024
Q3 		$431K Buy
17,500
+4,000
+30% +$104K ﹤0.01% 8578
2024
Q2 		$359K Sell
13,500
-17,600
-57% -$561K ﹤0.01% 8759
2024
Q1 		$1.28M Buy
31,100
+21,300
+217% +$931K ﹤0.01% 6419
2023
Q4 		$403K Sell
9,800
-1,100
-10% -$25.7K ﹤0.01% 8549
2023
Q3 		$214K Buy
10,900
+400
+4% +$9.81K ﹤0.01% 9768
2023
Q2 		$261K Sell
10,500
-7,900
-43% -$203K ﹤0.01% 9332
2023
Q1 		$503K Sell
18,400
-77,300
-81% -$2.44M ﹤0.01% 8295
2022
Q4 		$3.27M Buy
+95,700
New +$4.03M ﹤0.01% 4602
2022
Q3 		– Sell
-5,400
Closed -$227K – 12561
2022
Q2 		$227K Sell
5,400
-4,300
-44% -$216K ﹤0.01% 10431
2022
Q1 		$653K Sell
9,700
-3,200
-25% -$218K ﹤0.01% 8739
2021
Q4 		$1.06M Sell
12,900
-800
-6% -$65.1K ﹤0.01% 7807
2021
Q3 		$1.13M Sell
13,700
-12,900
-48% -$1.14M ﹤0.01% 7843
2021
Q2 		$2.05M Sell
26,600
-8,500
-24% -$590K ﹤0.01% 6563
2021
Q1 		$2.32M Buy
35,100
+2,500
+8% +$191K ﹤0.01% 6046
2020
Q4 		$2.77M Buy
32,600
+8,100
+33% +$279K ﹤0.01% 4711
2020
Q3 		$578K Sell
24,500
-29,400
-55% -$852K ﹤0.01% 7030
2020
Q2 		$1.81M Buy
+53,900
New +$2.29M ﹤0.01% 4761

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors's ARVN Position: Q2 2026 in Review

Citadel Advisors reduced its Arvinas (ARVN) stake by 47% in Q2 2026, selling an estimated $5.22M and leaving 620,973 shares worth $5.16M. The position accounts for ﹤0.01% of the portfolio, ranked #4664.

Citadel Advisors first reported a position in ARVN in Q3 2018 and has held it in 29 quarters since. The position peaked at $99.3M in Q4 2023. 201 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • Citadel Advisors held 620,973 shares of Arvinas worth $5.16M as of Q2 2026.
  • Citadel Advisors sold 560,015 Arvinas shares in Q2 2026, an estimated $5.22M.
  • Arvinas made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4664 holding.
  • Citadel Advisors first reported a position in Arvinas in Q3 2018 and has held it in 29 quarters since.
  • Citadel Advisors's Arvinas position peaked at $99.3M in Q4 2023.
  • 201 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.